Valuation: WEED, Inc.

Market Cap 4.03M 3.46M 3.23M 2.96M 5.58M 386M 5.64M 38.27M 14.88M 194M 15.15M 14.82M 642M P/E 2024
-7.8x
P/E 2025 -4.28x
Enterprise Value 4.52M 3.87M 3.62M 3.31M 6.25M 433M 6.32M 42.87M 16.67M 217M 16.97M 16.6M 719M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
40.53%
Yield 2024 *
-
Yield 2025 -
1 day+17.28%
1 week+12.61%
Current month+33.83%
1 month+45.00%
3 months-6.18%
6 months+6.33%
Current year-26.23%
1 week 0.02
Extreme 0.0232
0.03
1 month 0.02
Extreme 0.022
0.03
Current year 0.02
Extreme 0.0159
0.05
1 year 0.02
Extreme 0.0159
0.08
3 years 0.02
Extreme 0.0159
0.15
5 years 0.02
Extreme 0.0159
0.49
10 years 0.02
Extreme 0.0159
15.2
Manager TitleAgeSince
Chief Executive Officer 73 2014-09-29
Corporate Secretary 49 2014-09-29
Director TitleAgeSince
Director/Board Member 49 2004-12-31
Director/Board Member 73 2004-12-31
Date Insider Type Main position Quantity % Market Cap.
8/18/26 Sell

Director

-50,000 0.0337%
2/24/26 Sell

Director

240,605 0.1770%
5/6/22 Sell

Director

30,000 0.0248%
Change 5-day change 1-year change 3-year change Capi.($)
+17.28%+12.61%-1.85%-58.03% 4.03M
+1.58%+5.23%+3.95%+25.80% 51.21B
+1.71%-0.61%+501.86%+547.81% 45.35B
-0.27%+8.30%+38.26%+18.70% 42.84B
+0.94%+1.85%+21.82%+89.50% 42.29B
+0.88%-3.48%+17.20%+53.83% 32.15B
-0.52%+4.71%+32.42%+137.90% 17.31B
+0.69%+2.39% - - 16.55B
+1.37%+6.63%+11.30%+32.98% 14.84B
-0.25%+7.25%+82.45%+49.42% 14.25B
Average +2.32%+2.82%+78.60%+99.77% 27.68B
Weighted average by Cap. +0.84%+3.07%+107.51%+138.57%

Financials

2024 2025
Net sales - -
Net income -511K -438K -409K -374K -706K -48.9M -714K -4.85M -1.88M -24.56M -1.92M -1.88M -81.25M -1.37M -1.18M -1.1M -1.01M -1.9M -131M -1.92M -13.02M -5.06M -65.98M -5.15M -5.04M -218M
Net Debt 292K 250K 234K 214K 404K 27.98M 408K 2.77M 1.08M 14.05M 1.1M 1.07M 46.48M 485K 416K 389K 355K 671K 46.44M 678K 4.6M 1.79M 23.32M 1.82M 1.78M 77.15M
Logo WEED, Inc.
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
Employees
2
Date Price Change Volume
26-08-25 US$0.0319 +17.28% 33,572
26-08-24 US$0.0272 -0.73% 3,157
26-08-21 US$0.0274 -5.58% 5,790
26-08-20 US$0.0290 +1.03% 15,640
26-08-19 US$0.0287 +1.40% 689
  1. Stock Market
  2. Stocks
  3. BUDZ Stock